Talk Title:

Frank Barry is Professor of Cellular Therapy at the Regenerative Medicine Institute (REMEDI), University of Galway Ireland. He has been involved in the cell therapy field for 3 decades, working in the US, Canada and Ireland in both industry and academic settings. He has significant contributions in advancing the field of stromal cell therapy in terms of basic research, manufacturing technology, clinical trials and commercialization. He has contributed to the fields of tissue engineering and regenerative medicine by developing innovative and successful cellular therapies for tissue repair, joint injury and arthritic disease.  In a large body of basic and translational research, he has contributed to our current understanding of the phenotypic attributes of mesenchymal stromal cells that make them attractive candidates for advanced therapeutics. He has also contributed to the development of methods for automated, efficient and scalable cell expansion for GMP application and has been a leader in the development of clinical protocols for patient testing. He has coordinated clinical trials designed to test the efficacy of stromal cell delivery as a treatment for osteoarthritis.  He contributes as a board member of multiple corporations and research bodies and has acted as an advisor to research agencies throughout Europe and North America.  He has published widely in the areas of cell technology and therapeutic applications in arthritic disease and his work continues to be highly cited.